RIO DE JANEIRO, BRAZIL - Argentina and Mexico are at the forefront of the fight against the coronavirus pandemic in Latin America. Argentine President Alberto Fernández announced on Wednesday in Buenos Aires that the two countries will produce up to 250 million doses of the experimental vaccine that Oxford University is developing together with the British laboratory AstraZeneca.
The doses will be ready during the first half of next year. Each dose will cost betweenUS$2 and US$4, a "cost" price enabled by an agreement with the Slim Foundation for the development of the regional project.
The vaccine is . . .